Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2025 Nov 18;110(12):e4205-e4214.
doi: 10.1210/clinem/dgaf201.

Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage

Queralt Asla  1   2   3 , Maite Garrido  4 , Eulàlia Urgell  5 , Sílvia Terzan  5 , Alicia Santos  1   2   6   7 , Nimmy Varghese  8   9 , Cihan Atila  10   11 , Betina Biagetti  6   12 , Franziska Plessow  13   14 , Mirjam Christ-Crain  10   11 , Anne Eckert  8   9 , Susan M Webb  2   6   7 , Elizabeth A Lawson  13   14 , Anna Aulinas  1   2   3   6
Affiliations
Clinical Trial

Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage

Queralt Asla et al. J Clin Endocrinol Metab. .

Abstract

Context: Increasing evidence supports the presence of oxytocin deficiency (OXT-D) in hypopituitarism and hypothalamic damage (HHD). Identifying an applicable and reliable test to diagnose OXT-D is an unmet need. Melatonin (MEL) might be a candidate for such a test as it regulates OXT release in animals.

Objective: This work aimed to examine the effects of melatonin on OXT release in HHD compared to healthy controls (HCs) and to describe the psychopathology, sexual function, and quality of life (QoL) and their associations with OXT.

Methods: This proof-of-concept study (NCT05319301) included 20 participants with HHD (11 women) and 20 HCs (11 women). Blood samples were collected over 120 minutes to assess plasma OXT. A linear mixed-effects regression model was used to evaluate the change in OXT in response to MEL in HHD compared to HCs.

Results: MEL significantly increased OXT at T90 vs T0 in HCs compared to the HHD group (difference 14.57 pg/mL 26% increase; 95% CI, 1.90-27.23; P = .02). The HHD group had more depression symptoms, alexithymia, impaired sexual function, and worse QoL compared to HCs. The mean percentage change in OXT from T0 to T90 was negatively associated with depressive and alexithymia symptoms in the HHD group and anxiety in both groups.

Conclusion: The reduced OXT response after MEL in HHD supports the existence of an impaired OXT response at least in a subset of patients with HHD. The associations between OXT changes and psychopathology suggest its role in mood and QoL. These findings support further investigation into MEL's role as a diagnostic tool to address OXT-D.

Keywords: arginine-vasopressin deficiency; hypopituitarism; melatonin; oxytocin; pineal gland; stimulation test.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Response of OXT levels over time (from T0 to T120) after MEL across groups (HHD vs HC). Dot represents the mean value of OXT and whiskers represent the SEM range. *P less than .05 (statistically significant change from T0 to T90 between groups). HC, healthy controls; HHD, hypopituitarism and hypothalamic damage; MEL, melatonin; OXT, oxytocin; T; time point.
Figure 2.
Figure 2.
Dot plot comparing the AUC of plasma OXT concentrations after MEL across groups (HC and HHD). Dots represent the AUC of OXT after MEL for each participant, plus signs represent the median of AUC of OXT after MEL across groups (HC and HHD), and dashed lines represent the interquartile range for each median. HC, healthy controls; HHD, hypopituitarism and hypothalamic damage; MEL, melatonin; OXT, oxytocin.
See this image and copyright information in PMC

References

    1. Lynch S, Merson S, Beshyah SA, et al. Psychiatric morbidity in adults with hypopituitarism. J R Soc Med. 1994;87(8):445‐447. - PMC - PubMed
    1. Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888‐3921. - PubMed
    1. Gimpl G. The oxytocin receptor system: structure, function and regulation. Physiol Rev. 2001;81(2):629‐683. - PubMed
    1. Baribeau . Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits. Front Neurosci. 2015;9:335. - PMC - PubMed
    1. Althammer F, Grinevich V. Diversity of oxytocin neurons: beyond magno- and parvocellular cell types? J Neuroendocrinol. 2017;30:e12549. - PubMed

Publication types